DOJ announces first health care company declination
Campus Eye avoided prosecution after voluntarily disclosing misconduct, cooperating with investigators, and remediating the wrongdoing.
-
By
-
Kathryn Wighton
-
August 13, 2026
-
Clinical Scorecard: DOJ Announces First Health Care Company Declination
At a Glance
| Category | Detail |
|---|
| Condition | Clinical topic addressed by the source article: DOJ Announces First Health Care Company Declination |
| Key Mechanisms | Mechanisms or clinical associations described in the source article. |
| Target Population | Health care companies and executives involved in misconduct related to health care fraud. |
| Care Setting | Care setting described in the source article. |
Key Highlights
- DOJ declined to prosecute Campus Eye Management Holdings LLC after voluntary disclosure and cooperation.
- Campus Eye agreed to repay $1 million to victims as part of the resolution.
- E. Bruce DiDonato indicted on multiple counts related to health care fraud and kickback schemes.
- The declination reflects the DOJ's Corporate Enforcement and Voluntary Self-Disclosure Policy.
- If convicted, DiDonato faces a potential maximum of 45 years in prison.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Clinical Best Practices
- Voluntary disclosure of misconduct can lead to declination of prosecution.
- Cooperation with investigations is critical for favorable outcomes.
Related Resources & Content
